Related Experiment Video

Updated: Jun 3, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Ubiquitination of K-Ras enhances activation and facilitates binding to select downstream effectors

Atsuo T Sasaki1, Arkaitz Carracedo, Jason W Locasale

  • 11Division of Signal Transduction, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.

Science Signaling
|March 10, 2011
PubMed

Insights

Monoubiquitination of K-Ras enhances its GTP loading and binding to downstream effectors like PI3K and Raf. This previously unidentified mechanism may contribute to Ras pathway activation in cancer.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Oncology

Background:

  • Ras proteins, specifically KRAS, are key regulators of cellular signaling pathways.
  • Dysregulation of Ras signaling, often due to KRAS mutations, is implicated in various cancers.
  • Ras activity is tightly controlled by guanine nucleotide exchange factors and GTPase-activating proteins.

Purpose of the Study:

  • To investigate the role of K-Ras monoubiquitination in regulating its GTP loading and effector binding.
  • To explore a novel mechanism for Ras activation.

Main Methods:

  • Site-directed mutagenesis to target lysine-147 in K-Ras.
  • Biochemical assays to measure GTP loading and effector binding affinity.
  • Analysis of wild-type and Gly12Val mutant K-Ras.

Main Results:

  • Monoubiquitination of lysine-147 in wild-type K-Ras enhances GTP loading.
  • Ubiquitination increases the binding affinity of the oncogenic Gly12Val K-Ras mutant to PI3K and Raf.
  • This modification provides a new mechanism for K-Ras activation.

Conclusions:

  • Monoubiquitination serves as a regulatory mechanism for K-Ras activity.
  • This post-translational modification can enhance GTP loading and effector interactions, potentially promoting oncogenesis.
  • Targeting K-Ras ubiquitination may offer new therapeutic strategies for KRAS-driven cancers.

More Related Videos

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein07:08

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein

Published on: January 16, 2020

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...